Final Program

228 MONDAY • MAY 16
1004 Health Care System and Patient Determinants of Loss to
Follow-Up During Tuberculosis Treatment in Capital City of
Cameroon/E.W. Pefura-Yone, P.T. Enono-Edende, H.K.
Fatime-Abaicho, A.D. Balkissou, A.P. Kengne, E. Afane-Ze,
Yaounde, Cameroon, p.A4475
1005 Treatment Outcomes of Hospitalised Adults Tuberculosis and
HIV Co-Infected Patients in a Suburban Centre in Nigeria/T.A.
Salami, Irrua, Nigeria, p.A4476
1006 Age, Dehydration, Respiratory Failure, Orientation
Disturbance, and Blood Pressure (A-DROP) Score Predicts
In-Hospital Mortality in HIV-Negative Non-Multidrug-Resistant
Smear-Positive Pulmonary Tuberculosis Patients/K. Nagai, N.
Horita, A. Narita, M. Ikeda, K. Nakashima, R. Ushio, H. Watanabe,
Y. Shibata, K. Tashiro, H. Nagakura, T. Tsukahara, M. Yamamoto,
T. Sato, T. Kaneko, Yokohama, Japan, p.A4477
1007 Mortality of Patients with Sensitive Tuberculosis in the
Tuberculosis Department of the Machava General Hospital in
Maputo, Mozambique/P.M. Zindoga, O. Augusto, S. Peleve, S.
Amade, A. Hassane, J. Pondo, A. Daniel, E. Nunes, Maputo,
Mozambique, p.A4478
1008 Negative Interaction of Diabetes Mellitus with Clinical
Characteristics and Treatment Success of Tuberculosis in
Indonesia/D. Arlinda, A. Yulianto, A.K. Syarif, A.D. Harso, R.I.
Sugiyono, M. Karyana, Jakarta Pusat, Indonesia, p.A4479
1009 What Is the Best Treatment Regimen for Isoniazid-Resistant
Tuberculosis? A Network Meta-Analysis/H.R. Stagg, R.J. Harris,
H.-A. Hatherell, M.C.I. Lipman, I. Abubakar, London, United
Kingdom, p.A4480
1010 An Evaluation of Factors Associated with Mortality Among
Drug Resistant Tuberculosis Patients /M. Seifert, S.B.
Georghiou, D. Catanzaro, C.S. Rodrigues, V. Crudu, T.C. Victor,
R.S. Garfein, A. Catanzaro, T.C. Rodwell, La Jolla, CA, p.A4481
1011 Association of Previously Treated Tuberculosis Using Second
Line TB Drugs with Conversion Rate of Multi Drugs Resistance
(MDR-TB) Patients in Indonesia/D. Handayani, N. Librianty, P.Z.
Soepandi, Dki Jakarta, Indonesia, p.A4482
1012 Role of Nutrition Status in Multidrug Resistant Tuberculosis
(MDR-TB) Conversion/N. Librianty, P. Soepandi, D. Handayani, A.
Fuady, Jakarta Timur, Indonesia, p.A4483
1013 Association of NFE2L2 Polymorphisms and Anti-Tuberculosis
Drug-Induced Hepatotoxicity/G. Ji, A.J. Sandford, J. He,
Chengdu, China, p.A4484
1014 An Updated Meta-Analysis on CYP2E1 RsaI/PstI and DraI
Polymorphisms and Risk of Anti-Tuberculosis Induced
Hepatotoxicity: Evidence from 26 Studies/J. He, F.-J. Wang, Y.
Wang, T. Niu, Chengdu, China, p.A4485
1015 Pregnancy Safety Assessment of 3 Months of Once-Weekly
Rifapentine and Isoniazid and 9 Months of Daily Isoniazid: A
Post-Hoc Analysis of the PREVENT TB and the iAdhere
Trials/R.N. Moro, N.A. Scott, A. Vernon, S.V. Goldberg, K.
Schwartzman, M. Narita, E.S. Machado, N.W. Schluger, M. Lopez,
C.C. Leung, R.E. Chaisson, R.W. Belknap, J. Sanchez, M.E.
Villarino, T. Sterling, Atlanta, GA, p.A7859
1016 Statin Adjunctive Therapy Enhances the Activity of the
First-Line Regimen Against TB in Mice/P.C. Karakousis, N.
Bruiners, M. Pinn, M. Zimmerman, B. Prideaux, V. Dartois, M.L.
Gennaro, N. Dutta, Baltimore, MD, p.A7860
1017 Treatment-Shortening Activity of Clofazimine, Administered at a
Range of Doses, in Combination with the First-Line Regimen for
Tuberculosis in the Mouse Model/N.C. Ammerman, R.V. Swanson,
E.M. Bautista, H. Guo, D.V. Almeida, S.-Y. Li, F. Betoudji, S. Tyagi,
E. Nuermberger, J.H. Grosset, Baltimore, MD, p.A7861
B108
POSTER DISCUSSION SESSION
ADVANCES IN PEDIATRIC LUNG FUNCTION
TESTING
2:15 p.m. - 4:15 p.m. MOSCONE CENTER
Room 3011 (West Building, Level 3)
Poster Viewing 2:15-3:00
Discussion 3:00-4:15
Chairing: P.D. Sly, DSc, MBBS, MD, Herston, Australia
P. Subbarao, MD, Toronto, Canada
G. Hall, PhD, Subiaco, Australia
M.H. Jones, MD, PhD, Porto Alegre, Brazil
801 Dynamic Volumes, Diffusing Capacity and Multiple Breath
Nitrogen Washout Indices in Ex-Premature Danish School
Children/J.K. Sorensen, A.K. Berg, A. Henriksen, F.F. Buchvald,
K.G. Nielsen, Copenhagen, Denmark, p.A4486
802 Multiple Breath Nitrogen Washout (MBWN2) and Fractional
Exhaled Nitric Oxide (FeNO) in Healthy and Asthmatic
Preschool Children/L. Vilmann, F.F. Buchvald, K.G. Nielsen,
Copenhagen, Denmark, p.A4487
803 Correlation of Lung Clearance Index (LCI) with Hyperpolarized
129Xe Pulmonary Magnetic Resonance Imaging (MRI): A
Preliminary Study of Well-Controlled Asthmatics/N. Kanhere, J.
Zheng, K. Kowalik, B. Zanette, B.P. Kavanagh, P. Subbarao, G.E.
Santyr, Toronto, Canada, p.A4488
804 Ventilation Inhomogeneity in Severe Acute Wheezing
Preschool Children as Measured by Nitrogen Based Multiple
Breath Washout/K. Kowalik, M. Schaap, C. Lepine, A. Dubeau, Z.
Lu, C. Racette, T. Moraes, K. Boutis, F.A. Ratjen, P. Subbarao,
Toronto, Canada, p.A4489
805 Monitoring Allograft Function in Post Lung Transplant
Children by Multiple Breath Washout Demonstrates Peripheral
Lung Ventilation Inhomogeneity/J.E. Kao, J.M. Zirbes, C.
Conrad, C. Milla, Stanford, CA, p.A4490
806 Effect of Tissue Nitrogen Excretion on Multiple Breath
Washout Measurements/M. Kane, S. Stanojevic, R. Jensen, F.A.
Ratjen, Toronto, Canada, p.A4491
807 Comparison of Reporting Two Versus Three Trials of the Lung
Clearance Index/M. Klingel, S. Stanojevic, R. Jensen, H. Webster,
S.D. Davis, G. Retsch-Bogart, F.A. Ratjen, Toronto, Canada, p.A4492
ATS 2016 • San Francisco